IKNL

What IKNL does

IKNL (Integraal Kankercentrum Nederland) is a Dutch non-profit knowledge foundation (Stichting) headquartered in Utrecht that operates the Netherlands Cancer Registry (NKR), a nationwide population-based cancer database in continuous operation since 1989. IKNL collects, validates, and disseminates cancer incidence, treatment, and outcomes data by integrating pathology records from PALGA, hospital discharge data from DHD, and demographic information from CBS and BRP, producing curated datasets that are notifiable under Dutch healthcare regulation. The organization serves hospitals, clinicians, researchers, government bodies (notably the Ministry of Health, Welfare and Sport), pharmaceutical and medical device companies, health insurers, and patient advocacy groups.

IKNL's core product surface comprises NKR Cijfers (a public-facing cancer statistics platform), Monitor Oncologische Zorg (an oncology care monitor), Oncoguide (a clinical decision-support tool for molecular tumor boards), the Nederlandse Kankeratlas (a regional cancer atlas most recently updated in April 2025), Palliarts (palliative care guidelines), and the Trialbureau clinical trial support service. Underlying technical infrastructure includes data integration pipelines for pathology, hospital, and national statistics data, and the Personal Health Train framework for federated, privacy-preserving analysis across distributed datasets.

IKNL operates as a public-interest knowledge institute under a non-profit legal structure. Its revenue model is anchored in multi-year government funding from the Dutch Ministry of Health, supplemented by contract research and data services delivered to academic researchers, pharmaceutical companies, and policy stakeholders. Following the merger with DICA, IKNL's scope extends beyond oncology into additional clinical audit registries, broadening both its mandate and its institutional scale (501-1,000 employees).

Name

IKNL

Legal name

Stichting Integraal Kankercentrum Nederland

Website

https://iknl.nl

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

501–1,000 employees

Short description

IKNL is a Dutch non-profit foundation operating the Netherlands Cancer Registry and providing cancer data, clinical guidelines, and research support to hospitals, clinicians, researchers, government, and pharmaceutical stakeholders nationwide.

Ownership category

akta.pro rank

Product category

Cancer Registry and Oncology Data Services

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Patient Registries & Chronic Disease Registry Analytics (HLACAHAH)

akta.pro secondary industry

Clinical Data Repositories (CDR) & Longitudinal Patient Records (HLACAIAH)

Keywords

• Cancer registry services
• Oncology data analytics
• Clinical decision support
• Palliative care guidelines
• Epidemiological research

Headquarters

HQ city

Nijmegen

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Government Funding: As a Dutch knowledge institute, IKNL receives government funding to fulfill its public mission of reducing the impact of cancer through data collection, research, and quality improvement.
2. Data Services: IKNL provides cancer registry data to doctors, hospitals, researchers, health insurers, pharmaceutical companies, government bodies, and professional associations for scientific research and statistics. Data requests undergo review by the Supervisory Committee of the NKR.
3. Research Support Services: The Clinical Trials Office supports research groups and medical specialists in scientific studies on cancer and palliative care, collecting and storing medical data in study databases.
4. Educational Programs and Guidelines: IKNL develops and supports guidelines for palliative care and oncology, and provides educational programs and training for healthcare professionals.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

IKNL operates the Netherlands Cancer Registry (NKR), a nationwide database of all Dutch cancer patients maintained since 1989, and delivers data services, evidence-based oncology and palliative care guidelines, clinical decision support (Oncoguide), quality monitoring tools, and research support through its Clinical Trials Office. Its offerings target Dutch hospitals, medical specialists, researchers, government bodies, and pharmaceutical companies seeking population-level cancer surveillance, treatment outcome analysis, and care quality improvement.

Differentiator

Problem solved

Functional benefit

Brands

• Nederlandse Kankerregistratie (NKR): Nationwide cancer registry database collecting data on cancer patients in the Netherlands
• Palliarts
• NKR Cijfers
• Nederlandse Kankeratlas
• Oncoguide

Products and services

• NKR Cijfers Publicly accessible online tool providing cancer incidence, survival, prevalence, mortality, and risk statistics per cancer type for the Netherlands, sourced from the NKR.
• Nederlandse Kankeratlas (Dutch Cancer Atlas) Interactive online tool visualizing the geographic distribution of cancer types across the Netherlands, including risk factors, population data, and statistical methodology.
• Oncoguide Clinical decision support tool providing knowledge-based recommendations to assist oncology professionals in clinical decision-making.
• Monitor Oncologische Zorg Online monitoring platform enabling hospitals to compare their cancer diagnoses and treatments against regional and national averages, sourced from Dutch Hospital Data (DHD/LBZ).
• Palliarts Mobile App Mobile application supporting palliative care professionals with guideline access and clinical decision support at the point of care.
• NKR Data Request Services Formal data access service providing qualified researchers, healthcare providers, and institutions with detailed NKR cancer registry data for scientific research, subject to Supervisory Committee approval.
• IKNL Trialbureau (Clinical Trials Office) Dedicated clinical trials office supporting research groups and medical specialists in the design, data collection, and management of scientific studies on cancer and palliative care.
• Kerncijfers palliatieve zorg Tool Online tool providing palliative care needs statistics for the Netherlands, enabling analysis of regional and demographic demand for palliative care services.
• Trendrapport Kanker in 2032 Comprehensive analytical report projecting cancer diagnoses, mortality, and survival trends through 2032 based on NKR and CBS (Statistics Netherlands) data.

Quantifiable outcome

• 71% average 5-year cancer survival rate in the Netherlands (up from 48% thirty years ago)
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature6 records

Partnerships

14 partnerships are on record, tiered core, major and minor.

• NictizcoreStrategic or Co-development Partner · 1 December 2024Nictiz (knowledge organization for digital information in healthcare) and IKNL signed a letter of intent to intensify collaboration on standardized data availability and reuse in oncological and palliative care. The partnership focuses on developing and managing information standards, supporting national and international harmonization of standards.
• NVDVcoreStrategic or Co-development Partner · 1 October 2024IKNL and NVDV collaborated on the report 'Kanker van het hoofd-halsgebied in Nederland' combining data from NKR and DICA Hoofd-halsoncologie (DHNA) quality registry.
• NVDV (Nederlandse Vereniging voor Dermatologie en Venereologie)coreStrategic or Co-development Partner · 1 May 2024IKNL and NVDV became strategic partners of the Zonvenant (Sun Pledge) initiated by the Nationaal Huidfonds. The partnership aims to prevent skin cancer through awareness campaigns about sun protection. IKNL contributes scientific evidence on skin cancer from NKR data. The pledge commits organizations to actively contribute to preventing skin cancer for minimum 3 years.
• Nationaal Huidfonds (National Skin Fund)coreStrategic or Co-development Partner · 1 April 2021Partner in the Nationaal Actieplan Huidkanker (National Action Plan Skin Cancer) launched by the Stuurgroep Huidkankerzorg Nederland, initiated by NVDV and IKNL. The partnership coordinates efforts to reverse the rising tide of skin cancer through prevention measures and research.
• Health-RIcoreStrategic or Co-development PartnerHealth-RI and IKNL signed a Memorandum of Understanding (MoU) to strengthen collaboration for better data availability in cancer research. The partnership aims to create an integrated healthcare data infrastructure as the key to high-quality medical-scientific research, innovation, and optimal care. Both parties signed to advance data-driven cancer research in the Netherlands and beyond.
• DICA (Dutch Institute for Clinical Auditing)coreStrategic or Co-development PartnerIKNL and DICA are in a process of merger (Fusie DICA-IKNL) to combine forces in cancer data collection and quality auditing. The merger aims to strengthen oncology networks and improve cancer care through integrated data and audit systems.
• PALGA (Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief)coreTechnology or IntegrationPALGA is the national pathology database that provides automated cancer notifications to IKNL. Data managers extract and validate cancer data from pathology reports. PALGA data enables nationwide cancer surveillance and early detection monitoring.
• DHD (Dutch Hospital Data)coreTechnology or IntegrationDHD provides hospital medical registration data used in the Monitor Oncologische Zorg. Collaboration enables hospitals to compare their cancer care data with regional and national benchmarks.
• CBS (Centraal Bureau voor de Statistiek)coreStrategic or Co-development PartnerIKNL uses CBS population and mortality data for cancer trend analyses and projections. The CBS provides open population data by gender, 5-year age categories, and mortality statistics by cause of death for epidemiological modeling.
• ENCR (European Network of Cancer Registries)majorStrategic or Co-development PartnerIKNL supplies information from the NKR to the European database of the European Network of Cancer Registries for international cancer surveillance and research collaboration.
• IARC (International Agency for Research on Cancer)majorStrategic or Co-development PartnerIKNL supplies cancer data to the International Agency for Research on Cancer for global cancer surveillance and research as part of the WHO's cancer monitoring program.
• Taskforce OncologiemajorStrategic or Co-development PartnerIKNL participates in the Taskforce Oncologie, which includes NFK, NVZ, NFU, NHG, SONCOS, and other stakeholders working to coordinate oncological care during the COVID-19 pandemic and beyond.
• PVHH (Patiëntenvereniging Hoofd-Hals)minorGTM or Marketing PartnerPatient organization for head and neck cancer that supports patients and their families. Collaborates with IKNL on research and awareness campaigns including the Make Sense campaign.
• Erasmus MCmajorStrategic or Co-development PartnerAcademic medical center collaborating with IKNL on cancer surveillance research, including the chair in Cancer Surveillance held by Prof. Valery Lemmens. Joint research on trends in cancer occurrence, treatment, and survival.

Scale indicators7 records

Recent moves7 records

Expansion highlights7 records

Emerging players

• Flatiron Health: US-based real-world oncology data company building longitudinal clinical datasets from EHRs for research and pharma use cases. Comparable as an oncology data platform, though commercial and EHR-anchored rather than population-registry based.
• COTA Healthcare: US real-world oncology data and analytics company serving providers, payers, and pharma. Comparable in providing oncology real-world evidence and benchmarking, though oriented to commercial customers rather than national surveillance.

Direct peers

• Swedish National Cancer Registry (Cancerregistret): Sweden's national cancer registry administered by the National Board of Health and Welfare, providing nationwide oncology surveillance — structurally analogous to IKNL.
• Norwegian Cancer Registry (Kreftregisteret): Norway's national cancer registry providing population-level incidence, survival, and prevalence data with research and policy support. Direct peer in the Nordic/European national registry ecosystem.
• Danish Cancer Society (Kræftens Bekæmpelse): Operates the Danish Cancer Registry and supports research, prevention, and patient support — closely mirroring IKNL's combined registry, research, and patient-oriented mission in a neighboring Nordic country.
• National Cancer Registry Ireland (NCRI): Ireland's national cancer registry collecting incidence and treatment data on the Irish population. Comparable in scale and scope to IKNL's nationwide registry mission.
• National Cancer Registration and Analysis Service (NCRAS): England's national cancer registry run within NHS Digital, performing population-level cancer data collection, analysis, and reporting. Direct functional peer to IKNL with analogous nationwide coverage and stakeholder model.

Broad incumbents

• SEER (Surveillance, Epidemiology, and End Results Program): NCI's US cancer surveillance program covering ~48% of the US population with longitudinal cancer registry data. A broader geographic incumbent operating under a similar registry-based paradigm for research and public health.
• IARC (International Agency for Research on Cancer): WHO's cancer research agency that aggregates national cancer registry data globally and runs Cancer Incidence in Five Continents. Indirectly competitive and overlapping with IKNL at the international surveillance layer; IKNL is a data contributor.

Others

• Dutch Hospital Data (DHD): Provides Dutch hospital medical registration data used by IKNL's Monitor Oncologische Zorg. Adjacent data infrastructure partner that supplies IKNL rather than competes, but operates in the same national clinical data ecosystem.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/iknl
• YouTubeyoutube.com/channel/UC-RQY-u7SFEhLB-rpTWy-Xg
• LinkedInlinkedin.com/company/iknl

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IKNL